Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Anakinra

Rebound effect in the form of exacerbation of vasculitic lesions symptoms following the discontinuation and drug tolerance

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Metadaten
Titel
Anakinra
Rebound effect in the form of exacerbation of vasculitic lesions symptoms following the discontinuation and drug tolerance
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55064-5

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Immune-globulin

Case report

Multiple drugs

Case report

Cemiplimab

Case report

Antineoplastics

Case report

Multiple drugs